Transcutaneous Nerve Stimulation for Chronic Kidney Disease
Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
Recruiting
N/A
Interventional Study
Chronic Kidney Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- NYU Langone Health · Other
Who this trial is looking for
This trial is looking for adults with chronic kidney disease (CKD) to test a new device. Participation involves using a nerve stimulation device to see how well it works and if it’s safe.
Are You a Good Fit for This Trial?
You may be able to join if
- I am between 18 and 80 years old
- I have chronic kidney disease stage 3-5
- My kidney function test shows an eGFR less than 60
- I am able to give informed consent
You may not be able to join if
- I use a pacemaker
- I am a prisoner
- I am pregnant or think I might be pregnant
- I have Parkinson's disease with problems controlling my autonomic functions
- I have had a heart attack in the past 4 weeks
- I am on maintenance dialysis
- I have epilepsy
- I have diabetes
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this pilot interventional study is to collect preliminary data on the application of a transcutaneous auricular vagal nerve stimulation (taVNS) device in patients with chronic kidney disease (CKD). This data will enhance understanding of the short-term safety, tolerability and effects of this novel therapeutic approach in the setting of CKD. The primary aims are to investigate the f…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
• Individual 18-80 years of age with CKD stage 3-5 (eGFR \<60 mL/min/1.73m2) on most recent outpatient labs.
Exclusion Criteria:
* Pacemaker dependent
* Prisoners
* Pregnant women. A pregnancy test will be offered if a subject is concerned about being pregnant.
* Not capable o…
Contacts